President Shaimiev has visited health agencies in Naberezhnye Chelny

12 August 2008, Tuesday

August 12, Tatarstan President Mintimer Shaimiev visited large health agencies in the city of Naberezhnye Chelny, Tatarstan.

On his working visit to the Naberezhnye Chelny, the President was accompanied by the First Vice-Speaker of the Russian State Duma, Oleg Morozov, the Tatarstan Health Minister, Airat Farrakhov, the State Adviser to the Tatarstan President on social issues, Tatiana Larionova, the Head of the Naberezhnye Chelny district authority Ildar Khalikov.

The trip started with visiting the out-patient dialysis centre "Euromedic". The capacity of the centre is 216 patients if working in four shifts. Mintimer Shaimiev familiarized himself with the work of the centre in detail. He said that patients with kidney diseases who reside in remote areas should be provided with transport to be able to get quality treatment in the center.

Airat Farrakhov said in his speech that the public health services of the republic are step by step reaching a very high level. State-of-the-art public health services are being provided, new equipment is being purchased. It is necessary to set up an inter-regional centre for providing hi-tech medical assistance, the estimated cost of which is 1.2-1.5 billion ruble and it should provide services to as many as 1.2 million people a year.

Ildar Khalikov emphasized that thanks to measures taken in Naberezhnye Chelny in recent years children's mortality fell to 4.9 per thousand.

"A state-of-the-art interregional diagnostic centre will be created in Naberezhnye Chelny," Mintimer Shaimiev told journalists after having visited all the medical agencies on the agenda. He said the issue was seriously discussed with the republican health minister and the mayor of the city. It means that there will be three such centres in Tatarstan - in Kazan, in Almetyevsk and in Naberezhnye Chlny - and they will provide the people of the republic with medical assistance services in full.

SUBSCRIBE FOR NEWS
All content on this site is licensed under
Creative Commons Attribution 4.0 International